课题基金 / 基金详情

Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells

Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
Ah 受体依赖性造血干细胞控制的信号通路
批准号:
8711463
负责人:
Thomas A Gasiewicz
金额:
$34.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2018-03-31

项目摘要

项目成果

Thomas A Gasiewicz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hematopoietic stem cells (HSCs) have the ability to self-renew and differentiate into all blood lineages. A balance among quiescence, self-renewal, proliferation, and differentiation is precisely maintained to preserve multi-lineage generation throughout the organism's lifetime, and during responses to stress, tissue damage, and pathogens. Although the dysregulation of these processes in HSCs has immense implications for human health, how this balance is regulated is not well understood. Recent data support the novel hypothesis that the aryl hydrocarbon receptor (AhR) is a physiological regulator of HSCs. These data support the contention that AhR acts as a negative regulator by curbing excessive or unnecessary proliferation and promoting HSC quiescence. While our lab has done much work to understand the biology associated with AhR disruption in HSCs, we have not yet identified AhR-regulated signaling pathways that define normal HSC function as well as play a role in altered function under conditions of AhR dysregulation. We hypothesize that the Wnt and/or HIF signaling pathways are critical for AhR-mediated regulation of HSCs. We also hypothesize that dysregulation of AhR expression in HSCs, through disruption of these pathways, results in accumulation of oxidative DNA damage that eventually restricts self-renewal and causes premature senescence. Using a combination of molecular and cell biology techniques, unique animal models, and signaling pathway analyses, we will determin AhR-regulated signaling pathways in HSCs that define AhR function and that may lead to, under conditions of dysregulation, to HSC senescence and hematopoietic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
  • 批准号:
    8556514
  • 项目类别:
  • 资助金额:
    $33.98万
  • 财政年份:
    2013
  • 负责人:
    Thomas A Gasiewicz
  • 依托单位:
Strategic Vision & Impact on Environmental Health
  • 批准号:
    8245860
  • 项目类别:
  • 资助金额:
    $14.71万
  • 财政年份:
    2011
  • 负责人:
    Thomas A Gasiewicz
  • 依托单位:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
  • 批准号:
    8189491
  • 项目类别:
  • 资助金额:
    $22.79万
  • 财政年份:
    2011
  • 负责人:
    Thomas A Gasiewicz
  • 依托单位:
EGCG Has Anti-prostate Cancer Activity by Inhibiting hsp90
  • 批准号:
    8332788
  • 项目类别:
  • 资助金额:
    $19.12万
  • 财政年份:
    2011
  • 负责人:
    Thomas A Gasiewicz
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: